Aging weakens circadian rhythms, but not the same way in every tissue
The clearest picture comes from a study that profiled gene expression rhythms across six tissues—hypothalamus, lung, heart, kidney, skeletal muscle, and adrenal gland—in young, middle-aged, and old mice. In general, aging reduced the number of rhythmically expressed genes, meaning fewer genes followed a daily cycle. That is a sign of weakened circadian control [2]. But the details differed by tissue: the hypothalamus and skeletal muscle of old mice showed a large reduction in genes peaking at only one phase of the day, suggesting a loss of timing diversity within those tissues [2].
This matters for the question because it means there is no single answer for 'the circadian clock' in aging. A tissue like the hypothalamus may lose rhythmic amplitude or shift its peak timing, while another tissue might keep more rhythms but change which genes cycle. The study also found clusters of genes that changed with age at specific times of day without being rhythmic—so some age effects are temporal but not circadian in the strict sense [2].
Polyamines can influence clock genes, at least in the hypothalamus
Polyamines—putrescine, spermidine, and spermine—are small molecules involved in cell growth and stress responses. In a hypothalamus-derived cell line (GT1-7 cells), treating cells with putrescine increased the expression of core circadian genes and GnRH, the hormone that controls reproduction, in a time-dependent way, with significant changes at 6-hour intervals [1]. The same study found that circadian gene mRNA was strongly and positively correlated with GnRH mRNA under putrescine treatment, and that disrupting circadian rhythmicity in the hypothalamus in living animals abolished the normal rhythmicity of both polyamines and GnRH [1].
These findings suggest that polyamines and the circadian clock are connected in the hypothalamus, and that polyamines may help sustain or modulate clock gene activity there. The study also reported that circadian gene mRNA levels were elevated in the adult hypothalamus but declined significantly with aging [1]. That is consistent with the idea that age-related polyamine decline could contribute to weaker hypothalamic clock function—but the study did not directly test whether polyamine loss causes the clock decline, so this remains a hypothesis rather than a demonstrated mechanism.
Metabolic rhythms lose coherence across tissues with age
A separate study in mice examined the circadian metabolome—the daily rhythms of small molecules—across multiple tissues in young and aged animals. It found striking tissue specificity in how aging affected the polyamine pathway, and in the brain it sampled the suprachiasmatic nucleus (SCN), the body's central clock [4]. The abstract reports a loss of temporal coherence in the circadian metabolome across tissues during aging, meaning that the daily timing of metabolic processes became less synchronized between tissues [4].
This is relevant because polyamines are part of the metabolome. If the polyamine pathway is affected differently in different tissues with age, that could contribute to tissue-specific changes in clock timing or strength. However, the study does not isolate polyamines as a cause, and its abstract does not provide details on whether polyamine rhythms themselves were lost or shifted. So the evidence supports a link between aging, polyamine metabolism, and disrupted metabolic timing, but not a specific causal chain.
Why timing and strength may change differently across tissues
The extracellular matrix (ECM)—the noncellular scaffolding around cells—is under circadian control, and aging changes its biochemical and mechanical properties. A review proposes that these age-related ECM changes could feed back to dysregulate circadian clocks, and that dampening of clocks with age could in turn compromise daily ECM maintenance in matrix-rich tissues [3]. This offers a possible explanation for why some tissues show larger clock changes than others: tissues with more ECM, like skeletal muscle or heart, might be more affected by this feedback loop.
The review also notes that many hallmarks of aging are regulators of circadian timekeeping, suggesting multiple routes by which aging could alter clocks [3]. Polyamines could be one such route, but the review does not discuss polyamines specifically. Taken together, the evidence supports a model in which aging weakens circadian rhythms through several tissue-specific mechanisms, with polyamine decline being a plausible contributor in the hypothalamus and possibly other tissues, but not yet established as a general cause.
Sources used in this answer
Polyamine-Associated changes in circadian gene expression and their relationship to GnRH-I expression
In hypothalamic cells, putrescine treatment increased core circadian gene and GnRH expression in a time-dependent manner, and circadian gene mRNA levels declined with aging in the hypothalamus.
AGE-ASSOCIATED DECLINE IN TISSUE CIRCADIAN CLOCK FUNCTION
Aging reduced the number of rhythmically expressed genes across six mouse tissues in a tissue-specific pattern, with the hypothalamus and skeletal muscle showing a large reduction in genes peaking at only one phase of the day.
The circadian clock and extracellular matrix homeostasis in aging and age-related diseases
A review proposes that age-related changes in the extracellular matrix may dysregulate circadian clocks, and that clock dampening with age could compromise daily ECM homeostasis in matrix-rich tissues.
Loss of temporal coherence in the circadian metabolome across multiple tissues during ageing in mice
In aged mice, the circadian metabolome lost temporal coherence across tissues, with striking tissue specificity in the impact of aging on the polyamine pathway.
AGING AND CIRCADIAN CLOCK
Aging is associated with a reduction in the number of rhythmically expressed genes and weakening of circadian control, with implications for timing of preventive measures and treatments.